商品标签为：'d-(+)-手性肌醇'
浏览为
排序由
显示 每页
D-(+)-手性肌醇，D-(+)-chiro-Inositol；95%
468045
别名：D-手性-肌醇；1,2,4/3,5,6-六羟基环己烷；D-chiro-Inositol；1,2,4/3,5,6-Hexahydroxycyclohexane
Empirical Formula (Hill Notation): C6H12O6 CAS号: 643-12-9 分子量: 180.16 EC 号: 211-394-0 MDL编号: MFCD00272608 PubChem化学物质编号: 24870460 NACRES: NA.22
Empirical Formula (Hill Notation): C6H12O6 CAS号: 643-12-9 分子量: 180.16 EC 号: 211-394-0 MDL编号: MFCD00272608 PubChem化学物质编号: 24870460 NACRES: NA.22
¥851.17
D-(+)-手性肌醇，D-(+)-chiro-Inositol；≥98.0% (HPLC)
74137
别名：D-手性-肌醇；1,2,4/3,5,6-六羟基环己烷；D-chiro-Inositol；1,2,4/3,5,6-Hexahydroxycyclohexane
Empirical Formula (Hill Notation): C6H12O6 CAS号: 643-12-9 分子量: 180.16 EC 号: 211-394-0 MDL编号: MFCD00272608 PubChem化学物质编号: 329765491
Empirical Formula (Hill Notation): C6H12O6 CAS号: 643-12-9 分子量: 180.16 EC 号: 211-394-0 MDL编号: MFCD00272608 PubChem化学物质编号: 329765491
¥429.95
最近浏览商品
-
石墨，Graphite；flakes, ≥98% carbon basis, +200 mesh particle size (≥70%), natural -
![图片 1-甲基-2-吡咯烷酮，1-Methyl-2-pyrrolidinone [NMP]；for Peptide Synthesis, ≥99.7% (GC)](https://www.bszh.cn/images/thumbs/0016887_1-2-1-methyl-2-pyrrolidinone-nmpfor-peptide-synthesis-997-gc_32.png "显示明细 1-甲基-2-吡咯烷酮，1-Methyl-2-pyrrolidinone [NMP]；for Peptide Synthesis, ≥99.7% (GC)")
1-甲基-2-吡咯烷酮，1-Methyl-2-pyrrolidinone [NMP]；for Peptide Synthesis, ≥99.7% (GC) -
DL-乳酸钠溶液，Sodium DL-lactate solution；syrup, 60 % (w/w), synthetic -
![图片 胆钙化醇 [维生素D3]，Cholecalciferol；≥98% (HPLC)](https://www.bszh.cn/images/thumbs/0000978_-d3cholecalciferol98-hplc_32.png "显示明细 胆钙化醇 [维生素D3]，Cholecalciferol；≥98% (HPLC)")
胆钙化醇 [维生素D3]，Cholecalciferol；≥98% (HPLC) -
N-甲基-d3-4-苯基碘吡啶，N-Methyl-d3-4-phenylpyridinium iodide；99 atom % D -
![图片 六甲基二硅氮烷 [HMDS]，Hexamethyldisilazane；20% solution in xylene](https://www.bszh.cn/images/thumbs/0013335_-hmdshexamethyldisilazane20-solution-in-xylene_32.png "显示明细 六甲基二硅氮烷 [HMDS]，Hexamethyldisilazane；20% solution in xylene")
六甲基二硅氮烷 [HMDS]，Hexamethyldisilazane；20% solution in xylene
